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ABSTRACT OF THESIS 
 
 
COMPUTATIONAL INVESTIGATION OF INJECTABLE TREATMENT STRATEGIES FOR 
MYOCARDIAL INFARCTION 
 
Heart failure is an important medical disease and impacts millions of people 
throughout the world. In order to address this problem, treatments that use biomaterial 
injected into the myocardium of the failing left ventricle are currently being developed. 
Through this treatment, the biomaterial injections can reduce wall stresses during the 
cardiac remodeling process. By using computational techniques to analyze the effects of 
a treatment involving the injection of biomaterial into the left ventricle after myocardial 
infarction, the material parameters of the hydrogel injections can be optimized. The 
results show that the hydrogel injections could reduce the global average fiber stress and 
the transmural average stress seen from optimization. These results indicated that the 
hydrogel injections could influence the stiffness in passive left ventricle tissue, but there 
is still need for more research on the active part of ventricular contraction. The conclusion 
is that hydrogel injection is a viable way to alter ventricular mechanical properties. 
KEYWORDS: Finite element modeling, Hydrogel injection, Myocardium infarction, Passive 
stiffness, Computational optimization 
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CHAPTER 1 
Background 
Myocardial infarction 
As the American Heart Association Statistic reported in 2011, cardiovascular 
disease is the leading cause of death in the United States, nearly 2200 die each day. And 
estimated 82.6 million American adults (>1 in 3) have 1 or more types of cardiovascular 
disease. In state of Kentucky, more than 40% adults have multiple risk factors. In terms of 
economic impact, the total cost due to cardiovascular disease exceeded $286 billion. It 
has been reported that more than a million people in the United States have a myocardial 
infarction (MI) each year. About half (515,000) of these people die as a result. About one-
half of those who die do so within one hour of the start of symptoms and before reaching 
the hospital. Even though heart failure is a significant medical burden to the developed 
world, there remains a need for better solutions to solve this problem. Before using 
modeling methods, the only way to observe MI is doing experiment. Now we can use 
finite element methods (FEM) to build the model of heart, so that it can reduce the cost 
and times of experiments. To solve this problem, a novel method called “Intra-myocardial 
biomaterial injection therapy” showed up in recent years. It can help patient to treat the 
heart disease [1]. The biomaterial injection can reduce the stress of the failing ventricular 
wall and act to retard the progression of heart failure. This method is based on the FEM 
model to observe the stress changed in the ventricular wall.  
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There are several models that can be used to represent the passive mechanical 
behavior of the left ventricle (LV). Certain models can also capture important detailed 
properties of heart failure. Some investigated influences include the constitutive 
nonlinear interactions between the responses in myocardium tissue to different loading 
patterns, the influences of the structure of laminar myofibre sheet, the effects of 
transverse stresses developed by the myocytes and the relationship between the 
architecture of collagen fibre and mechanical behavior in healing scar tissue after MI [2].  
For example, isotropic models were developed by Demiray in 1976 [3]. For transversely 
isotropic models, Humphrey et al. construct a pseudostrain-energy function to determine 
the relation of passive cardiac tissue [4]. Guccione et al. developed a transversely isotropic 
model and predicted that the fiber strain curves generated from the model agreed closely 
with experimental data. Additionally, they showed that fiber structure can alter the stress 
in  the endocardium in the passive LV, torsion, residual stress and material anisotropy [5]. 
Costa et al. also used transversely isotropic models to analyze mechanics behavior in 
large-scale anatomical models [6]. Recently, orthotropic models could help researchers 
to analyze more details about the orthotropic properties of myocardium. In 2001, Costa 
et al. reported that the constitutive properties of myocardium were three dimensional, 
anisotropic, nonlinear and time dependent. Based on these properties, they 
demonstrated orthotropic models in the study of MI [2].  
Morphology and structure 
 The structure of heart is quite complicated. In a human, the size is almost like a 
person’s fist, and yet it plays as a crucial role in a body. The mass of a human’s heart is 
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between 250-350 grams. It is located anterior to the vertebral column and posterior to 
the sternum. The heart consists of four chambers, namely the right atria, which receives 
oxygen-poor blood from the body, the right ventricle, which pumps blood into the lungs, 
the left atria, which received oxygen-rich blood from the lungs, and the LV, which pumps 
blood into the body [7]. The structure of heart was shown in figure 1.  
 
Figure 1 the structure of heart  
The wall of human heart can be considered as composed of three major layers, 
epicardium, myocardium and endocardium. The endocardium lines the inside of the four 
chambers and it is a serous membrane, with approximate thickness 100 µm, consisting 
mainly of epimysial collagen, elastin and a layer of endothelial cells, the latter serving as 
an interfacial layer between the wall and the blood [7].  
The fiber orientation in myocardium has been studied for many years. The 
distribution of stress in the LV wall is impacted by both the fiber tension and fiber 
orientation. In 1969, the paper by Streeter et al. [8] indicated that the myocardium wall 
has a well-ordered distribution of fiber varying from -60° to 60° (from epicardium to 
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endocardium), relative to the circumferential direction, in normal heart. Besides this, in 
comparison to normal heart, the fiber angles changed in pressure-overload heart. As 
mentioned in Carew et al. [9], the fiber angle was tested between -67.5° and -90° in 
endocardium and ranged from 67.5° to 90° in epicardium. The methods used to study the 
fiber orientations are described in detail the papers [8, 9].  
Treatment Methods 
 Methods to treat MI vary. In 2006, a work done by Wall et al. utilized a finite model 
to evaluate the effect on cardiac wall stress of injecting non-contractile biomaterial 
injections into the LV wall [1]. As in previous work by Guccione et, al., they used finite 
element models to simulate the volume change in the LV cavity. It was shown that the 
relationship between the stroke volume and stresses in end-diastole state are affected by 
the local fiber orientation [10]. There are many treatments involving the use of cardiac 
restraint devices. For instance, the CorCap (Acorn Cardiovascular Inc.) uses Dacron wraps 
(Figure 2), and the Heart Net (Paracor Medical Inc.) uses nitinol wraps to provide 
ventricular support during heart failure [11-13]. Other companies, such as the Myosplint 
(Myocor Inc.), provide interior ventricular support to address dilation from heart failure. 
The primary goal of each of these devices is to reduce the stress in the ventricular wall 
during heart failure. Myosplint uses their device to change the geometry of the LV and 
reduce the burden in dilated cardiomyopathy [14, 15].  
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Figure 2 Cardiac restraint devices. (A) Dacron woven mesh (B) Elastic nitinol metal wrap. 
(From Blom et all. [16] and Klodell dt all. [17]) 
 
To treat heart failure, injections made of biomaterial can be used to reduce the 
stress in LV wall. In Kichula et al. [17] a new method combined experimental and 
computational techniques to estimate the mechanical properties after the hydrogel 
injection in normal myocardium. In order to determine how injectable volume and 
mechanical parameters influence myocardium wall, experimental measurements were 
first used to obtain hydrogel injection volumes by magnetic resonance imaging (MRI). 
Subsequently, biaxial testing of tissue sample was performed. Finally, based on the 
observation from experimental measurements a constitutive model was used to fit 
parameters to ex vivo samples of myocardium. This method was used to mimic the 
response of the injected myocardium by building finite element models that used those 
properties. The results indicated that biomaterial could be used to reduce the wall stress 
during the LV remodeling.  
6 
Constitutive behavior 
The material behavior of active and passive myocardium is considered as 
hyperelastic, incompressible, and transversely isotropic [5, 18]. The relationship used to 
describe myocardium mechanics by the strain energy function, W, is shown below. These 
properties were assigned as the material parameters in the finite element model. This 
model is a phenomenological model, which is transversely isotropic with respect to the 
local fiber direction [5]. 
𝑊 =
𝐶
2
[exp(𝑄) − 1]                                                                                                       (Eq 
1) 
𝑄 = 𝑏𝑓𝐸11
2 +𝑏𝑡(𝐸22
2 + 𝐸33
2 + 𝐸23
2 + 𝐸32
2 ) + 𝑏𝑓𝑠(𝐸12
2 + 𝐸21
2 + 𝐸13
2 + 𝐸31
2 )                                   (Eq 
2) 
Where E11 is strain in fiber direction, E22 is strain in cross-fiber direction, E33 is radial strain 
transverse to the fiber direction, and the rest are shear strains, and C, bf, bt, and bfs are 
the diastolic material parameters [17].  
 Systolic contraction can be modeled as the sum of the passive stress derived from 
the strain energy function and active fiber directional component T0 [19]. T0 is a function 
of time (t), peak intracellular calcium concentration (Ca0), sarcomere length (l) and 
maximum isometric tension achieved at the longest sarcomere length (Tmax) [18].  
𝑆 = 𝑝𝐽𝐶−1 + 2𝐽−2/3 𝐷𝑒𝑣 (
𝜕?̃?
𝜕𝐶
) + 𝑇0{𝑡, 𝐶𝑎0, 𝑙, 𝑇𝑚𝑎𝑥}                                                         (Eq 3) 
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where S is the second Piola-Kirchoff stress tensor, p is the hydrostatic pressure, J is the 
Jacobian of the deformation gradient tensor, C is the right Cauchy-Green deformation 
tensor, and Dev is the deviatoric projection operator [20].  
C and B depend on the deformation gradient F, and are defined by  
C = FTF and B = FFT                                                                                                                    (Eq 4) 
Dev (·) = (·) - 
1
3
 ([·]:C)C-1                                                                                                           (Eq 5) 
?̃? is isochoric contribution of the strain energy function.  
W = U(J) + ?̃?(?̃?)                                                                                                                       (Eq 6) 
Where U is the volumetric contribution.  
At end-systole state, the active fiber directional stress component is defined by a time-
varying elastance model which is reduced to [21] 
𝑇0 =  
1
2
𝑇𝑚𝑎𝑥
𝐶𝑎0
2
𝐶𝑎0
2+𝐸𝐶𝑎50
2 (1 − cos(
0.25
𝑚𝑙𝑅√2𝐸11+1+𝑏
+ 1)𝜋)                                                    (Eq 7) 
where m and b are constants, and 𝐸𝐶𝑎50
2  is the length-dependent calcium sensitivity 
given by,  
𝐸𝐶𝑎50
2 =
(𝐶𝑎0)𝑚𝑎𝑥
√𝑒𝑥𝑝[𝐵(𝑙𝑅√2𝐸11+1−𝑙0)]−1
                                                                                          (Eq 8) 
where B is a constant, (𝐶𝑎0)𝑚𝑎𝑥 is maximum peak intracellular calcium concentration, 
𝑙0 is the sarcomere length at which no active tension develops, and 𝑙𝑅 is the stress-free 
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sarcomere length [19]. The material properties of active myocardium can be found in 
[22].   
 
Mechanical behavior of the passive myocardium  
The passive myocardium mechanical behavior plays a significant role in 
understanding myocardium infarction. Most of our preliminary knowledge of the 
mechanical behavior of the passive myocardium was originally from uniaxial test on 
papillary muscles or trabeculae carnae [23, 24]. After several years, people found that 
uniaxial test cannot describe the multi-axial behavior of the passive myocardium. Biaxial 
test was reported by Demer and Yin to investigate the anisotropic behavior of passive 
myocardium [25]. They determine passive myocardium mechanical properties in canine 
myocardium. Non-linear elasticity and viscoelasticity with strain-rate dependence in the 
stress-strain relations were found under biaxial testing in passive myocardium [25]. Later 
Yin et al. reported that myocardium is consistently stiffer in the direction of the muscle 
fibers than it is in the orthogonal cross-fiber direction [24]. 
During biaxial testing, the Cauchy stress can be defined as:  
𝜎11 =  
𝐶
2
𝑒
𝑏𝑓
4
(𝜆1
2−1)2+ 
𝑏𝑡
4
((𝜆2
2−1)2+(
1
𝜆1
4𝜆2
4−1)
2)
(𝑏𝑓(𝜆1
4 − 𝜆1
2) − 𝑏𝑡 (
1
𝜆1
4𝜆2
4 −
1
𝜆1
2𝜆2
2))    (Eq 9) 
  𝜎22 =  
𝐶
2
𝑒
𝑏𝑓
4
(𝜆1
2−1)2+
𝑏𝑡
4
((𝜆2
2−1)2+(
1
𝜆1
4𝜆2
4−1)
2)
(𝑏𝑡 (𝜆1
4 − 𝜆1
2 −
1
𝜆1
4𝜆2
4 +
1
𝜆1
2𝜆2
2))           (Eq 10) 
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where 𝜎11  and 𝜆1  are the stress and stretch ratio in the circumferential (myofiber) 
direction, respectively, and 𝜎22 and 𝜆2  are the stress and stretch ratio in the longitudinal 
(cross-fiber in-plane) direction, respectively. The stretch ratios and normal components 
of Green-Lagrange strain are related by 𝐸𝑖𝑖 =
1
2
(𝜆𝑖
2 − 1), where i=1,2,3. 
CHAPTER 2 
Study 1: Effects of Hydrogel Injection on Health Myocardium  
Despite advances in FE models of injection treatment, there has yet to be direct 
comparison between experimental results and models to better understand how 
materials can influence stress behavior after injection.  In the current investigation the 
focus was on the experimental generation of injection volume/shape data in LV explants 
using magnetic resonance imaging (MRI) and their mechanical properties using biaxial 
testing.  The biomaterial hydrogel injections used in this study were made of 
methacrylated hyalutonic acid (MeHA).The experimentally measured information was 
then employed directly in a FE model of an LV treated with an injection distribution 
pattern that was previously explored in an in-vivo study, to investigate stress levels based 
on experimentally derived, rather than theoretical input values. This investigation will 
ultimately provide a better understanding of the relationship between injectable material 
properties (i.e., mechanics and volume) and stress reduction post-MI and insight on 
material design criteria for injectable biomaterials to attenuate LV remodeling. The work 
presented in this section was done in collaboration with the Burdick Lab at the University 
of Pennsylvania. 
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Methods 
Non-Contrast Magnetic Resonance Imaging (MRI) 
Hydrogel distribution and volume within the myocardium was assessed by 
mimicking the experimental in vivo work of Ifkovits et al.[26]. The research team at UPenn 
obtained ovine hearts from a local butcher shop. Three minutes after mixing of the MeHA 
with initiators, 0.3 mL of the hydrogel formulation [4 wt% MeHA, 5Mm APS/TEMED in 
phosphate buffered saline (PBS)] was injected into the explanted ovine LV myocardial 
tissue. After 30 minutes, treated samples (hydrogel injected into myocardium tissue) 
were obtained from the heart within the region from the epicardium to endocardium. 
After 30 minutes, the tissue with hydrogel material injected was fixed in 4% formalin 
overnight and paraffin embedded by using standard histological techniques. Injected 
explants were imaged using MRI without contrast agents by adjusting image parameters 
to exploit material intrinsic properties; a spin echo pulse sequence was employed and the 
echo time (30-60 ms) was adjusted for optimal contrast. Voxel size was also altered (0.234 
x 0.234 x 1.00 mm3 vs. 0.234 x 0.234 x 0.234 mm3) to optimize resolution.   
Biaxial Testing 
Biaxial testing is a useful way to obtain two-dimensional mechanical behavior. 
Previous uniaxial testing has demonstrated fiber stress-strain relationship in one direction. 
According to Walker et al. finite element analysis with only uniaxial contraction stress is 
insufficient to model the mechanical behavior in myocardium tissue [27]. However, the 
mechanical behavior of myocardium tissue has two direction (fiber direction and cross-
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fiber direction) to calculate. Biaxial testing is used to avoid the limitation of the uniaxial 
testing. To characterize the mechanical behavior of myocardium tissue, biaxial testing was 
employed to identify the two directions stress-strain relationship specifically. Biaxial test 
has been used previously for test infarct material properties [28]. 
In the current study, injected explant tissue and untreated myocardium samples 
were prepared and a total of 5 samples were tested per group. Samples were collected 
from the mid-myocardial region and trimmed to ~7 x 7 mm2 with a thickness of ~2 mm.  
Average thickness values were calculated to compute cross-sectional areas in order to 
determine the stress in each loading directions. The samples were speckle-coated with 
Verhoeff’s stain. Also, samples were equilibrated for ~1 h in PBS at RT. Biaxial test requires 
the free expansion of the sample edges, thus finger-like grips were made out of 
waterproof sandpaper (T214 Norton) (~75 x 5 mm2) to accomplish this [29]. Grips were 
painted white to enhance contrast and glued (Locite 454). Brass 0.5 mm markers were 
painted black to enhance contrast. The black makers used to track the strain during the 
biaxial test process (Fig 3). Three 25 x 1 mm “fingers” were put at the free end so that 6 
“fingers” were formed (3 on the top and 3 on the bottom) [17]. Testing was performed 
by grip-to-grip strain control; all samples were preconditioned, exposed to a 1 hour hold, 
and then tested. Preconditioning included prestraining to 0.01 equibiaxial strain and then 
equibiaxially straining to 0.20 for 5 cycles at 0.10 strain/min.  The test protocol was 
identical to the preconditioning parameters; data and images from the final loading curve 
of each test were used for experimental data analysis.   
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Figure 3 Representative biaxial testing preparation sample.  
 
 Stress and strain data obtained from biaxial testing were used to estimate the 
nonlinear material parameters for building the finite element model. To obtain the tissue 
strain data, 2-D displacement maps were rendered using the speckle-coated surface via 
digital image correlation (Vic2D 2009, Correlated Solutions). The basic deformation 
variable for the description of the local kinematics is the deformation gradient F; and for 
an incompressible material, there is a constraint on J, where  
J = det F ≡ 1                                                                                                                             (Eq 11) 
Associated with F are right and left Cauchy-Green tensors C and B.  
C and B are defined by  
C = FTF and B = FFT                                                                                                                 (Eq 12) 
Also important for what follows is the Green-Lagrange (or Green) strain tensor, defined 
by 
E = 
1
2
 (C-I)                                                                                                                                 (Eq 13) 
Where I is the identity tensor.  
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The gradient F was calculated in both the longitudinal and circumferential 
directions from the displacement map of each image by finding the least-squares solution 
with a Matlab algorithm developed and described by Szczesny et al [30].  
Finite Element model 
In order to determine the influence of hydrogel injections on myocardial wall 
stress, two different FE models were built, one with hydrogel injections and one without. 
FE models were modified from Wenk et al [19]. The wall thickness was approximately 1.3 
cm near the equator of the LV and 0.8 cm near the apex. The inner diameter of the 
endocardial wall near the equator was 4 cm. The myocardium had fiber orientation that 
varied transmurally in the wall tissue. The angle assigned from epicardium to 
endocardium was -37° to 83°, respectively. The model was assigned 20 hydrogel injections 
around the free wall. The number of regions was based on work by Ifkovits et al.[31], 
where the 20 hydrogel injections were put into an ovine anteroapical infarct region. The 
resulting finite element models for the current study are shown in Figure 4. The pattern 
of 5 circumferential by 4 longitudinal injections were assigned in the region of the LV free 
wall (i.e., no injections in the septum). In the model, the blue part represents injections 
and the red part the myocardium tissue. The shape of hydrogel injections were modeled 
as ellipsoidal, and the material properties in these regions were assumed to act like a 
composite material, i.e, the injection sites were a combination of myocardium and the 
hydrogel polymer. The shape and volume of the injections was based on the MRI of 
injected explant tissue.  
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According to Holmes et al.[32], the passive properties of the myocardium begin to 
stiffen four to six hours after MI. Since the model was built to mimic the initial time frame 
after myocardium infarction, it was assumed that the myocardial properties were 
unchanged. Therefore, the remote region properties were created as same as the 
properties in the control case biaxial results. The material properties of the hydrogel 
injection tissue region were obtained from the experimental biaxial testing of samples 
taken from the center of the ellipsoidal composite site (Fig 4). Since each injection was 
0.3 mL, the total amount of volume added to the myocardium wall was 6 mL. The wall 
thickness was increased to 1.4 mm. Compared to the control case model, the longitudinal 
dimensions were not changed. The bfs value was set to 12, and it was determined from 
the literature [27].  
 
Figure 4 Captured from LS-PrePost (Livemore Software Technology Corporation, Livemore, 
CA) 
 
Results 
15 
Non-contrast MRI 
The proton makeup of a water swollen HA hydrogel is different from that of tissue; 
thus, when injected into an explant, the endogenous properties of the composite 
hydrogel/tissue region are different compared to tissue alone.  It is not completely 
understood how much of this is due to changes in proton density or relaxation times, yet 
hydrogels are detectable without the inclusion of contrast agents.  Initial studies were 
performed to understand whether the injected macromer would be present in the tissue, 
if it is not crosslinked into the gel.  To address this, MeHA was injected into explants 
without initiator and washed for up to 5 days.  After 3 days, there were negligible 
differences between the control tissue and the tissue washed free of macromer (Figure 
5).  Xc meant circumferential direction and Xl meant longitudinal direction. 
 
Figure 5 MRI images showed composite in control myocardium and uncrosslinked 
macromer tissue at day 3.  
16 
 
Figure 6 MRI images and 3D images showed tissue with hydrogel injection injected.  
 
The injected composite material was found to spread in the major directions 
(circumferential, longitudinal, and transmural). The 3-D images could distinguish the 
composite injection region from the myocardium tissue (Fig 6). The dimensions and 
volume of hydrogel composite injections were estimated from the MRI data.  The average 
length in circumferential, longitudinal, and transmural directions was found to be 1.725 
± 0.25, 0.575 ± 0.15, and 0.875 ± 0.096 cm, respectively. The volume was calculated as 
0.420 ± 0.162 mL, which was larger than the original volume 0.3 mL because of the 
hydrogel injections dispersing within the tissue. After the hydrogel was injected into the 
myocardium tissue, it dispersed evenly with the fibers, as could be seen from the figure 
below, G means hydrogel injection region (Fig 7). The smallest dimension of the hydrogel 
composite region was in longitudinal direction. This is because  the laminar architecture 
of the fiber sheet in myocardium, the hydrogel injections were dispersed between layers 
[17].  
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Figure 7 G represents hydrogel injections. 
Biaxial testing 
Biaxial testing was conducted on 5 control samples and 5 hydrogel composite 
samples. The curve fit results had a good agreement with experimental data for both 
control and composite samples. The resulting stress-strain curves were then fit in order 
to determine the parameters for the constitutive model in Equation 9 and 10. All of the 
parameters from the curve fitting procedure are reported in Table 1A and 1B for the 
control and composite case. The average parameters for each case are given in Table 2. 
The curve fit parameters were plugged into Equation 9 and 10 to generate curves shown 
in Figure 9. As the figure indicated, the stiffness in composite samples was higher than it 
in control samples. And the anisotropy was reduced in composite samples compared to 
control samples. The parameters C, bf and bt were determined from the optimization by 
using genetic algorithm.   
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Table 1 Biaxial testing results of curve fitting for control (A) and injected region (B). 
(A) 
Sample # C (kPa) bf bt R2 (circ) R2 (long) 
1 0.656 25.44 4.604 0.995 0.995 
2 0.817 14.85 1.876 0.988 0.951 
3 0.859 28.73 3.217 0.994 0.989 
4 0.597 20.20 3.018 0.995 0.965 
5 0.470 15.63 4.017 0.988 0.966 
 
(B) 
Sample 
# 
C (kPa) bf bt R2 (circ) R2 (long) 
1 1.179 17.28 9.154 0.996 0.996 
2 0.907 8.862 7.731 0.993 0.991 
3 0.859 17.87 6.533 0.987 0.970 
4 0.484 28.46 4.831 0.981 0.906 
5 0.667 15.52 7.527 0.997 0.995 
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Figure 8 Left: Curve fit results for representative samples of control myocardium and 
hydrogel/tissuel composite 
 
Figure 9 Right: Average curve fit results for representative samples of control 
myocardium and hydrogel/tissuel composite 
Table 2 Average biaxial testing results of curve fitting for control and composite samples. 
Case C (kPa) b
f
 b
t
 
Control 0.679±0.160 20.97±6.05 3.346±1.04 
Composite 0.819±0.262 17.60±7.05 7.155±1.60 
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In order to see the influences in anisotropy, the “modulus” in different strain 
ranges was examined. Myocardial physiological stain has been reported to range from 0.1 
to 0.15 [31, 33-35].To account for the lower and higher ends, a mechanical assessment 
was performed between 0.05 and 0.10 and between 0.10 and 0.15 Green-Lagrange strain, 
where 0.05-0.10 corresponded to the linear toe region in stress-strain curves (Figure 10). 
Results demonstrated that in longitudinal direction, the moduli of composite samples 
were higher than in control samples in all Green-Lagrange strain ranges with significant 
changes at 0.10-0.15. However this trend was not as clear in the circumferential direction. 
It is well known that healthy normal myocardial tissue is anisotropic, where stiffness in 
circumferential direction is higher than in longitudinal direction. Overall the results shown 
the stiffness increased more in the longitudinal direction than it in the circumferential 
direction. As a result, the anisotropy ratio for the composite tissue was decreased 
compared to control myocardium. It means stiffening in an anisotropic manner enhanced 
the influence of hydrogel treatment in decreasing stress.  
 
Figure 10 Calculated moduli from tissue strain for control and composite samples in 
longitudinal direction (left) and circumferential direction (right).  
Longitudinal Direction
 Circumferential Direction
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Figure 11 Calculated anisotropic ratio. 
 
Finite element model simulation 
All of the cases were run on either a 12-core or 32-core computer node. To 
compare the influences between injected explant and baseline sample, two models were 
built, one with injections and one without injections. Both models used the material 
parameters obtained from biaxial testing. End-diastole stress in different regions in FE 
model were calculated. As the results shown below, the global average of fiber stress was 
reduced by roughly 14% due to the presence of the injections. The transmural average, 
which represents a local change in stress was reduced by 26%. In order to assess the 
influence of mechanical properties verses wall thickening, since hydrogel injection 
induced both, simulations were conducted where the properties of the composite regions 
were assigned to be the same as the control myocardium. Therefore only wall thickening 
effects altered the stress distribution. It can be seen that the reduction in stress is 10.4% 
for the global average and 19.9% for the transmural average. Thus, increased stiffness, 
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due to the hydrogel injection, reduced the stress more than just thickening the ventricle 
wall alone. The influence of altering the anisotropy of the injection region was explored. 
This provides insight that could be used to tune the development of the hydrogel.  When 
bt was assigned to be 1, the fiber stress increased by 6%, whereas when bt was assigned 
to be equal to bf, the fiber stress decreased by 11%. That is because of the Poisson’s effect. 
Thus, as cross-fiber stiffness increases (reducing anisotropy) the fiber stress decreases 
even further.  
Table 3 End-diastolic myofiber stress averaged over different regions. 
Case Global 
 kPa (% 
diff) 
Circumferential 
kPa (% diff) 
Longitudinal 
kPa (% diff) 
Transmural 
kPa (% diff) 
Control 2.89 3.35 3.04 3.37 
Composite 2.49 (-13.9%) 2.75 (-18.1%) 2.38 (-21.9%) 2.49 (-26.0%) 
Composite 
w/ control 
props 2.59 (-10.4%) 2.85 (-14.9%) 2.48 (-18.4%) 2.70 (-19.9%) 
 
 
 
 
 
23 
Discussion 
This study determined the influence of hydrogel injections within the wall of 
normal myocardium of the LV. The results indicated that the injected hydrogel increases 
mechanical stiffness in the longitudinal direction and reduces stress along the fiber 
direction. Previous studies have reported that hydrogel material could reduce the stress 
of the LV wall, but they were not considering the interaction of the hydrogel material with 
myocardium tissue. Kortsmit et al, performed a study where the distribution of hydrogel 
in the infarcted heart was simplified and during their computational study, bulk layers of 
hydrogel were used to determine the stress reduced in LV wall [36]. In addition, Wenk et 
al, developed an FE model to defining the injection pattern and material parameters. The 
results indicated that stress could be reduced during cardiac cycle [19].  
In the current study, the biaxial testing results indicated that the injected hydrogel 
material alters the stiffness of myocardium tissue, generally resulting in a larger 
mechanical influence in the longitudinal direction than in the circumferential direction 
compared to control myocardium. The results reported in Figure 10 support the trend 
that normal myocardial tissue is anisotropic, however, when compared to control 
samples, composite tissue resulted in decreased anisotropy (Fig 11).  
This study also indicated that the hydrogel composite injections increase the 
stiffness of the myocardium/hydrogel composite region along cross-fiber direction when 
compared to control myocardium, and also reduce the global average stress along the 
fiber direction. . It was found that increasing wall thickness, due to the injections, can 
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reduce stress even if the stiffness was not altered. However, when the cross-fiber stiffness 
was increased, this led to the largest decrease in fiber stress. 
 Overall this approach could predict further reduction by changing the formulation 
of materials and material properties. There are a wide range of materials that have been 
injected into myocardium and with some systems there is tenability in properties. For 
instance, by altering the stiffness of the formulation, the stress may be reduced more. 
This study showed that a formulation that is stiffer overall could further reduce stress.  
One limitation of the current study is that it only used data on the passive stiffness due 
to hydrogel injections in LV. The contractility in the injection region was not assessed. The 
other limitation is that this study should be used in a beating heart instead of an explanted 
heart. Further research is needed to study the active part during heart contraction in a 
living LV.   
 
CHAPTER 3 
Study 2: Effects of Hydrogel Injection on Myocardial Infarction 
Method  
This study was performed using Hydroxy-ethyl methacrylate functionalized 
hyaluronic acid (HeMA-HA) hydrogels, which were injected into a MI. In this study, the 
hydrogel was functionalized to exhibit controlled and tunable mechanics and degradation 
once cross-linked, in an attempt to assess the temporal dependency of mechanical 
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stabilization in LV remodeling [37]. This study was aimed to determine the influences of 
hydrogel injection on in-vivo properties. During this study, data was used from pigs that 
underwent ligation of the coronary artery to create MI. Magnetic resonance images (MRI) 
of LV were collected at 1 weeks, 4 weeks, and 8weeks post MI, where end-diastole 
pressure and volume were obtained. Endocardium and epicardium surface data were 
used to generate finite element models for each case. By using the mesh generator 
TrueGrid, finite element models with experimental surface data were built. After this, 
Matlab was used to assign the fiber angles to the finite element model in the remote 
myocardium. The optimization software LS-OPT was used to adjust the material 
parameters and infarct fiber angles in the FE model and run the simulations.. The 
optimization was used to compare the FE predicted strain and volume to that measured 
from MRI. The “best” result was the set of material parameters and MI fiber angles that 
minimized the difference between the experimental measurement and simulation output. 
The work presented in this section was done in collaboration with the Burdick Lab and 
Gorman Lab at the University of Pennsylvania. 
MRI 
To measure 3D strain in myocardium, the 3D SPAMM MRI tissue-tagging sequence 
and a 3D optical flow method were used in this study [38].  In previous studies, 2D analysis 
techniques with optical flow method has been used to estimate LV deformation from 
tagged CMR images. This method has limited ability to precisely capture the complex 
radial, circumferential and longitudinal motion associated with normal and diseased 
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hearts [39, 40]. The 3D analysis technique is a deformable model which fit to either the 
tag line material points extracted from the image date. Another method used for tagged 
CMR analysis called harmonic phase method (HARP), which uses tag phase to estimate 
the underlying tissue displacements [41]. However, this was not used in this study. 
Ten custom 2mm platinum makers were sutured to the epicardium around the 
infarct periphery immediately following infarct induction to enable infarct localization in 
subsequent MRI acquisitions and post-processing. For regional strain measurements from 
3D SPAMM images, infarct boundaries were identified using the previously placed 
platinum epicardial makers and comparing to landmarks on late-gadolinium enhanced 
(LGE) images (Fig 12). LGE images could show infarct region more clearly. Detailed 3D 
deformation patterns derived from the heart of sample pig were illustrated in the figures 
below. Figure 13 represented phase 1-4 from the sample PMR120 at one week. Figure 14-
15 showed the endocardium and epicardium boundaries, as well as the normal region 
compared to infarct region. Strain data was obtained from end-diastole because during 
that time there was less noise than the other time points. Too much noise could disturb 
the images and make them not clear.   
 
Figure 12 PMR120 1week S12 LGE and S12 LGEMarkers 
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Figure 13 PMR120 1week S16 phase 1-4  
a b c d  
Figure 14 a) PMR120 1week S16 Endocardium. b) PMR120 1week S16 Endocardium Infarct. 
c) PMR120 1week S16 Epicardium. d) PMR120 1week S16 Epicardium infarct.  
 
e f g h  
Figure 15 e) PMR120 1week S17 Phase4 Infarct. f) PMR120 1week S16 Infarct. g) PMR120 
1week S16 End-diastole phase. h) PMR120 1week S17 Phase4 Infarct Markers 
Six control cases (PMR132, PMR134, PMR119, PMR120, PMR135, and PMR137) 
and nine treated cases (PMR124, PMR126, PMR128, PMR129, PMR130, PMR131, MEP13, 
MEP17 and MEP19) were used in this study. PMR and MEP were the animal IDs.  
Experimental data was obtained from pigs that underwent ligation site of the coronary 
artery to create a posterolateral-MI (Fig 16). For infarct induction, pigs were anesthetized 
and the LV free wall exposed through a left thoracotomy. Pigs were monitored with 
electrocardiography throughout the procedure. A posterior MI was induced by suture 
ligation of the left circumflex artery (LCX) and select obtuse marginal (OM) branches. In 
nearly all cases, this pattern of coronary ligations produces an infarct comprising 20-25% 
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of the LV [42]. MRI compatible, thin platinum wire markers were placed on the heart to 
outline the infarct area. Tracking these markers enabled quantitative assessment of 
infarct area expansion over time. Thirty minutes post-MI, control pigs received twenty 0.3 
mL injections of saline. The treatment cases were given twenty 0.3 mL injections of the 
hydrogel. Real time 3D echocardiographs and hemodynamic data were obtained at 
baseline, immediately prior to MI, 30 minutes post-MI, and 30 minutes post injection (Fig 
19). MRI scans were performed 5-7 days prior to MI (baseline) and at 1, 4, 8 and 12 weeks 
post-MI. For each MRI scan, a pressure transducer was guided into the LV for cardiac 
gating. Cardiac MRI was used to noninvasively assess global and regional cardiac structure 
and function through a series of three scans: 1) cine imaging to assess global and regional 
morphology, 2) delayed contrast enhancement (DCE) with gadolinium to assess infarct 
area, and 3) SPAMM tagging to assess regional wall motion and function. Pictures were 
taken to show the evaluation of myocardium infarction region samples (Fig 17-18).  
 
Figure 16 PMR126 Epicardiual view.  
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Figure 17 PMR126 Terminal.  From left to right: anterior, left lateral and posterior.   
  
Figure 18 left: PMR126 Infarct size 18.8% (LV areal 8250mm2, infarct area 1550mm2) Right: 
MEP13 Infarct size 16.78% (LV 8022mm2, infarct area 1346mm2) 
 
 
Figure 19 Echocardiographic images of MEP19 sample at 12 weeks scan. 
 
Finite element model  
The model used in this study was built by a commercial mesh generate software, 
TrueGrid (XYZ Scientific, Inc., Livermore, CA, USA). By using the contour points from the 
MRI data, LV was generated at early diastolic state. Each FE model built based on the 
contour data got from the experimental data. And the distance from the cap to the 
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bottom of the model was varies from 5 cm to 6.4 cm which dependents on the scan range 
set from MRI. After importing the edge surface data of endocardium and epicardium from 
MRI, the base was fitted to the experimental LV. Figure 20 shows the epicardium and 
endocardium surfaces build from the surface data from MRI. Then the software could fill 
up the volume between endocardium and epicardium with elements. These elements 
represent the myocardium and MI. The finite element model was a 3-D model, consisting 
of three dimensions which were longitudinal, circumferential and transmural respectively. 
Each direction had its numbers of elements which was same numbers in each sample 
model. The model has 12 elements along longitudinal direction, 36 elements along 
circumferential direction and 3 elements along transmural direction. The fiber angles 
were assigned to finite element model through a custom MATLAB script. For the remote 
region from epicardium to endocardium, the fiber angle were assigned from -37° to 83° 
(Fig 21). The parameterization of the fiber angles in the infarction region were determined 
from the optimization scheme. In this study, fiber angle search range was set to be -50° 
to 0° in epicardium and 50° to 90° in endocardium respectively (Fig 21).  
 
Figure 20 Capture from LS-Prepost of surfaces in LV.  
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Figure 21 Fiber angle orientation from endocardium to epicardium and infarct region.   
 
Results 
The optimization process was performed by a commercial software LS-OPT 
(Livemore Software Technology Corporation, Livemore, CA). LS-OPT is a standalone 
design optimization and probabilistic analysis package with an interface to LS-DYNA. The 
design changes based on experience and this design approach not always lead to the 
desired result, but it lead to a “best” design. LS-OPT provides a simulation environment 
that allows distribution of simulation jobs across multiple processors. The optimization 
process begin with a random initial point and narrow down the design space to get the 
best result. The design space is governed by the passive parameters in the remote region 
(4 parameters), the passive parameters in the infarct region (4 parameters), and the MI 
fiber angles (2 parameters). The optimization algorithm used to minimize the results 
range was a genetic algorithm (GA). The optimization compared simulation and 
experimental strain, with a constraint to have the simulation match the measured volume 
within plus and minus 8%. GA is also called a metaheuristic and it belong to the large class 
INFARCT
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of evolutionary algorithms. There were 30 iterations used during the optimization, with 
100 simulations conducted per iteraton. Thirty iterations took almost 20 hours to get the 
final result. Six 1 week samples, five 4 week samples and four 8 week samples were been 
through 30 iterations simulation before get the best results (Table 4-6).  
The optimization was seeking to determing the following: C, Bf, Bt, and Bfs were 
parameters of remote region and C_I, Bf_I, Bt_I, and Bfs_I were parameters of infarct 
region. These table also showed epicardium angle, endocardium angle and MSE (mean 
squared error). In order to determine the influences in treated myocardium wall, plot of 
biaxial testing results were represents clearly below. Figure 22-23 show the average 
stiffness changed during the post-MI time course for both the remote and treated MI with 
hydrogel injections. 
 
Table 4 Parameter values of six 1 week samples from optimization. 
1wk MEP13 MEP17 MEP19 pmr127 pmr126 pmr130 
C (hPa) 1.338 1.236 9.141 8.385 4.821 2.94739 
Bf 42.44 57.08 3.904 74.32 22.24 55.8006 
Bt 41.31 2.346 49.17 1.532 32.29 23.5864 
Bfs 48.36 38.56 24.74 49.02 38.24 46.1552 
C_I (hPa) 89.36 59.01 9.904 27.58 14.44 58.3569 
Bf_I 208.6 212.1 245.1 71.05 244.9 200.023 
Bt_I 2.603 26.71 13.91 11.36 14.27 4.11997 
Bfs_I 7.798 18.3 14.68 56.44 13.03 6.90619 
epiangle -5.563 -49.68 -1.094 -1.294 -3.672 
-
0.01684 
endoangle 40.5 43.17 40.34 61.63 66.61 75.7309 
MSE 5.418 9.077 7.694 4.985 4.671 6.79207 
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Table 5 Parameter values of five 4 week samples from optimization. 
4wk MEP13 MEP17 pmr130 pmr126 pmr129 
C (hPa) 5.716 1.064 12.98 65.22 4.373 
Bf 55.03 89.48 54.58 1.004 38.32 
Bt 23.83 45.24 3.159 28.87 23.11 
Bfs 49.2 47.44 49.89 4.869 46.58 
C_I (hPa) 12.68 133.6 20.61 59.06 21.88 
Bf_I 204.6 58.58 64.13 45.39 238.9 
Bt_I 11.52 2.7 9.473 6.392 20.27 
Bfs_I 57.52 1.219 42.44 5.779 13.72 
epiangle -11.11 -2.088 -2.269 -3.062 -0.3384 
endoangle 49.56 46.32 26.12 25.55 48.66 
MSE 5.718 7.062 7.118 6.644 3.983 
 
Table 6 Parameter values of four 8 week samples from optimization. 
8wk pmr126 pmr128 pmr130 pmr131 
C (hPa) 3.655 5.646 12.38 4.203 
Bf 86.25 13.13 49.47 28.51 
Bt 39.67 11.72 6.32 31.89 
Bfs 46.2 49.17 49.11 48.24 
C_I (hPa) 10.07 11.38 7.61 2.793 
Bf_I 60.33 224.1 177 227.3 
Bt_I 13.78 5.447 7.43 59.72 
Bfs_I 22.4 11.57 7.461 59.69 
epiangle -0.2211 -0.3513 -2.185 -0.5784 
endoangle 0.5581 35.42 27.88 45.62 
MSE 10.51 10.02 15.9 4.068 
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Figure 22 Plot of infarct region stiffness get from simulated biaxial tests of six 1week 
samples, five 4week samples and four 8week samples. 
 
Figure 23 Plot of infarct region stiffness get from simulated biaxial tests of six 1week 
samples, five 4week samples and four 8week samples. 
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In order to see the influence during the process, plots were generated for each 
time point (Fig 24-26).   
 
Figure 24 Plot of stiffness in infarct region and remote region at 1 week.  
 
 
Figure 25 Plot of stiffness in infarct region and remote region at 4 week 
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Figure 26 Plot of stiffness in infarct region and remote region at 8 week 
 
Figure 27 Biaxial results of 8 week infarct region and 8 week remote region on treated 
cases.  
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Figure 28 Biaxial results of 8 week infarct region and 8 week remote region on control 
cases. 
The material parameter data was obtained from optimizations by using LS-OPT. 
Curves were plotted by using a simulated biaxial extension test coded in a custom Matlab 
script and the averaged stresses (fiber stress and cross-fiber stress) are shown. Material 
parameters C, Bf, and Bt, were plugged into Eq 9 and Eq 10 to calculate the stiffness in 
infarct region and parameters C_I, Bf_I, and Bt_I were used to calculate remote region 
stiffness. Figure 27 showed the compared biaxial test result in both infarct region and 
remote region at 8 weeks on treated cases. In additional, according to the thesis work 
done by Mojsejenko, Figure 28 represented the average stress-strain data at 8 weeks on 
control cases (untreated infarct). It can be seen that the treated infarct is much stiffer 
than the untreated infarct at 8 weeks post-MI. This means the hydrogel is able to maintain 
higher stiffness for a longer period of time. 
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Discussion 
This work was used to determine the changes to in-vivo material properties of a 
myocardium infarction over a serial time course. In the previous studies, FE modeling was 
used to determine the deformation and contractility of LV wall caused by myocardium 
infarction. A method for estimating the contractility during heart failure was developed 
by Sun et al, from the tagged MRI, myocardial strain, LV volume and LV FE model were 
calculated [43]. Wenk et al. also use this method to develop an FE model to study a sheep 
with posterolateral infarction [44]. However, the focus of the current work was on the 
passive properties of the myocardium and infarct tissue. 
Table 4-6 obtained from LS-OPT to investigate the material parameter values at 1 
week, 4 week and 8 week. As seen from those optimization results, the parameters for 
infarcted region were significantly higher than remote region. Specifically, the value of 
Bf_I was not only higher than Bf, but also much higher than Bt and Bfs. That means hydrogel 
injections will cause a high stiffness along fiber direction compared to remote region and 
cross-fiber direction.  
Biaxial stress results were calculated by a Matlat script. As seen from results of 
Figure 22-23, it can be seen clearly that the stiffness increased significantly in infarcted 
region than remote region due to the hydrogel injection. And then the stiffness become 
decreased over the time of remodeling process at 4week and 8week. It is clearly to see 
the increased stiffness at 1 week from Figure 24. This result indicated that hydrogel 
injections can be used to treat infarcted heart to reduce the onset of MI bulging during 
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contraction. At 4 weeks, Figure 25 showed that the stiffness still stiffer in infarcted region 
than the remote region, but there was a reduce trend in anisotropy compared to it at 1 
week. That means the stiffness of infarcted region was decreased before 4 week study. 
As the stiffness decreased over time, however as seen from figure 26, the stiffness still 
higher in infarcted region compared to the remote region in treated heart at 8 weeks. The 
Hydrogel had the most influence at the initial phase of myocardium infarction, and the 
anisotropy was much bigger than 4 weeks and 8 weeks. Figure 27 and Figure 28 
represented an average stress-strain curves comparison between the treated cases and 
control cases at 8 weeks.  The trend of curves indicated that the stiffness was higher in 
treated cases than the control cases, that was because the effect of hydrogel injections.  
It is important to observe stiffness changes in LV wall. That was because after the 
myocardium infarction occurred, the infarcted tissue died. Then tissue become thinner 
and lose contractility. When high pressure loaded into LV, the thinner infarcted tissue 
could not resist the load. Hydrogel injection could make the infarct tissue stiffer than 
remote tissue and also make the LV wall thicker. Also, it could reduce stretching and stress 
around the infarct region. This is beneficial to prevent dilation of the LV over the time of 
the remodeling process during myocardium infarction. Another important factor was that 
before dilation of LV, mitral valve was closed to make sure that the blood could pump into 
the body and would not flow back into the atrium. After MI, high pressure in LV could 
make mitral valve open and leak blood so that it would cause a terrible interruption in 
pumping blood function.    
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There are a wide range of injection therapies that can be used for myocardial 
infarct tissue. By using this method, future studies can find better hydrogel composite 
injection design based on this study. Future studies will add more design of hydrogel 
injections shape, numbers and material. Also instead of just focusing on the LV, more 
studies need to have research on the right ventricle. Finally, there could be additional 
studies to see if there is a better algorithm instead of genetic algorithm to optimize the 
material properties during the optimization.  
 
CHAPTER 4 
Conclusions 
To treat cardiovascular disease, medical data was used to create realistic virtual 
representations of the LV and then utilize predictive computational modeling to improve 
diagnostic and treatment strategies. By using the contour data from MRI and biaxial 
testing, finite element models were generated for determining material parameters and 
the geometry of hydrogel composite injection. Hydrogel injected into a MI could increase 
the stiffness of the LV wall, thus decreasing bulging during contraction that leads to 
inefficient ejection. By altering the material parameters with hydrogel injections, 
myofiber stress and strain were obtained. This information can be used to generate better 
treatment for the reduction of adverse remolding after myocardium infarction. This study 
provide insight on how to optimize material parameters to alter the stiffness during LV 
remolding, and reduce stress on myofibers.   
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